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Genes involved in acute rejection (AR) after organ transplantation remain to be further elucidated. In a previous work we have
demonstratedtheunder-expressionofVE-Cadherinbyendothelialcells(EC)inARfollowingmurineandhumanhearttransplan-
tation. Serial sections from 15 human kidney Banﬀ-graded transplant biopsies were examined for the presence of VE-Cadherin
and CD34 staining by immunohistochemistry (no AR (n = 5), AR grade IA (n = 5), or AR grade IIA (n = 5)). Quantiﬁcation of
peritubularECstainingwereevaluatedandresultswereexpressedbythepercentageofstainedcellspersurfaceanalysed.Therewas
no diﬀerence in CD34 staining between the 3 groups. VE-Cadherin expression was signiﬁcantly reduced in AR Grade IIA when
compared to no AR (P = .01) and to AR grade IA (P = .02). This study demonstrates a reduced VE-Cadherin expression by EC in
AR after renal transplantation. The down-regulation of VE-Cadherin may strongly participate in human AR.
Copyright © 2007 Ana Roussouli` eres et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Acute rejection, observed after renal transplantation, has a
signiﬁcantimpactforlong-termrenalallograftsurvival.Even
though its incidence was reduced by new immunosuppres-
sive drugs, it remains a major problem after renal transplan-
tation. Acute rejection is a cell-mediated immune response
that is initiated by the recognition of CD4+ T cells by the
major histocompatibility complex (MHC) class II antigens
on antigen-presenting cells (APCs) of the graft [1–4]. MHC
c l a s sI Ia n t i g e na c t i v a t e sC D 4+ T-lymphocytes, which subse-
quently release cytokines. Released cytokines target vascu-
lar endothelial cells, the ﬁrst cells to be recognized by the
host’s immune system, and induce the expression of adhe-
sion molecules and chemokines implicated in T-lymphocyte
adhesion and extravasation. Initial transient adhesion of T-
lymphocytes mediated principally by selectins induce the
rolling of the T-cells and their subsequent activation and
adhesion on the endothelium via other adhesion molecules
such as ICAM-1 and VCAM-1. This adhesion stage provides
the necessary signal for full T-cell activation leading to T-
lymphocytes transendothelial migration [5].
Endothelial cells forming the interface between donor
and recipients are the ﬁrst donor cells to be recognized
by the host’s immune system. Endothelial cells coating the
capillaries that act as a barrier between the donor organ
and recipient bears the MHC class II molecules. They are
highly responsive to cytokines and express adhesion and
other molecules implicated in T-lymphocyte adhesion and
extravasation. Such endothelial control in cell migration re-
quires an eﬀective intercellular adhesion, so called cell junc-
tion, between the endothelial cells. Morphologically, three
types of organelles constitute the endothelial cell junctions
[6].Tightjunctionssealthecellstoeachother.Gapjunctions2 Journal of Biomedicine and Biotechnology
Table 1: Patients demographics.
Characteristics No acute rejection Acute rejection grade IA Acute rejection grade IIA P value
(n = 5) (n = 5) (n = 5)
Recipient age (years) 55 ±13 55 ±43 2 ±12 .02
Recipient sex (M/F) 1/4 5/0 4/1 .1
Donor age (years) 54 ±20 34 ±20 32.6 ±14 .1
Donor sex (M/F) 4/1 3/2 4/1 .9
Ischemic time (h) 17.9 ±3.61 5 .4 ±3.71 7 .1 ±1.0. 2
Time between
Transplantation and 2.8 ±1.9 1244.8 ±2037.7 270.9 ±178.3. 0 1
biopsy (days)
Serum creatinine (μmol/L) 238.3 ±137.1 212 ±77.45 286.4 ±150.11 .7
allow exchange of ions and small molecules between adja-
cent cells. Adherent junctions mediate the physical contacts
between cells and anchor the actin cytoskeleton. Cell-cell ad-
hesion structures have been studied and some membrane
proteins have been described such as PECAM-1 or CD31 [7];
α5β1a n dα2β1 integrins [8], V-Cadherin [9], and vascular
endothelium cadherin (VE-Cadherin) [10–12]. The extrava-
sation of lymphocytes in rejecting renal allografts is thought
to take place in activated peritubular capillaries [13].
To date, the exact mechanisms involved in acute rejec-
tion after solid organ transplantation are not completely un-
derstood. In a previous work [14] we have demonstrated
that VE-Cadherin is under expressed in acute rejection
in a murine heterotopic heart transplantation model and
in acute rejection following human heart transplantation.
Murinemacroarraysresultswerevalidatedinmiceandinhu-
mans by immunohistochemistry and quantitative real-time-
polymerase chain reaction (Q-PCR). In this study we have
performed immunohistochemical staining of VE-Cadherin
in human biopsies after renal transplantation. We demon-
strate that VE-Cadherin is also under expressed in acute re-
jection after renal transplantation.
2. MATERIALS AND METHODS
2.1. Patients
This study comprised transplant biopsy specimens from 15
patients (66% of men with mean age of 47 ± 15 years).
All patients received deceased donor kidney transplants. Af-
ter transplantation, all patients received induction therapy
with anti-lymphocyte globulin or anti IL-2 receptor and
triple-therapy immunossupression (cyclosporine, steroids,
and mycophenolate mofetil). Details relating to important
clinical parameters in each group are given in Table 1.
2.2. RenalSpecimens
Needle kidney transplant biopsies were performed solely to
deﬁne the diagnosis and management of patients with acute
deterioration of allograft function in accordance with in-
stitutional guidelines. Renal allograft tissues were obtained
from transplant recipients undergoing ultrasound guided
biopsies from December 2002 to August 2003. Biopsies were
performedbetween1dayand1–6yearsafterrenaltransplan-
tation (453, 4±1118,8 days). Specimens were formalin ﬁxed
andparaﬃnembeddedorsnapfrozeninliquidnitrogen.Fif-
teen renal transplant biopsy specimens were examined.
2.3. Histopathologicalstudy
Paraﬃns e c t i o n s( 4 μm) were stained with Periodic acid
Schiﬀ (PAS) and graded for acute rejection using the Banﬀ
criteria [15]. Fifteen kidney transplant biopsies showing no
rejection (n = 5), acute rejection grade IA (n = 5), or acute
rejection grade IIA (n = 5) were examined.
2.4. Immunohistochemistry
Serial sections were used for VE-Cadherin and CD34 im-
munostaining. Negative controls were performed with the
use of irrelevant isotype matched antibodies. Positive con-
trol was performed using human spleen tissues that show a
large number of endothelial cells.
2.4.1. VE-Cadherin
Sections were incubated for 1 hour with a mouse antihuman
VE-Cadherin monoclonal antibody (1:50, Chemicon Inter-
national, Temecula, CA, USA) followed by a goat antimouse
immunoglobulin(Dako,France),whichwasthenrevealedby
the streptavidin-biotin immunoperoxidase method.
2.4.2. CD34
Sectionswereincubatedfor1hourwithamouseanti-human
CD34monoclonalantibody(1:50,Dako,France)followedby
an antimouse biotin (Dako, France) which was then revealed
by the streptavidin-biotin immunoperoxidase method.
2.5. Quantitativeanalysis
Sections were assessed by two independent observers (AR,
BM), scored according to the number of VE-Cadherin
stained endothelial cells in peritubular capillaries and the
number of CD34 stained cells. Sections were analyzed with
a Leica DMLB microscope (Leica Microsystems, Germany)Ana Roussouli` eres et al. 3
(a) (b) (c)
Figure 1: Periodic acid schiﬀ (PAS) staining (X 400) of renal biopsies. (a) No acute rejection, (b) acute rejection grade IA, (c) acute rejection
grade IIA. Arrows show peritubular capillary endothelial cells.
directly coupled to a 3CCD colour camera (JVC, Argenteuil,
France). Quantiﬁcation of VE-Cadherin and CD34 staining
was evaluated using image analysis software (Perfect Image,
Claravision Orsay, France). Positive VE-Cadherin and CD34
labelled peritubular endothelial cells were counted in 10
high-power ﬁelds for each sample (X630 magniﬁcation). Re-
sults were expressed by the percentage of surface labelled
stained cells. Mean values were obtained for each specimen
and used for statistical analysis.
2.6. Statisticalanalysis
Kruskal-Wallisnonparametrictestwasusedtocompareclin-
ical characteristics between the 3 groups. In order to take
into account the variability between ﬁelds for each sample,
variance analysis for repeated measures was used to compare
VE-Cadherin immunohistochemical staining between the 3
groups. When this global test was signiﬁcant, Fisher LSD
post-hoc test was further used when comparing between 2
groups.P values <.05 were considered to indicate statistically
signiﬁcant diﬀerences.
3. RESULTS
3.1. Patientscharacteristics
The demographics are summarized in Table 1.T h em e a n
time between transplantation and allograft biopsy was 431±
1081 days (range 1–4298 days). There was no statistical dif-
ference between donor age, donor and recipient sex or is-
chemic time. Serum creatinine (mean ± SD) was not statisti-
cally diﬀerent between groups. All patients with histopatho-
logic diagnosis of acute rejection received steroid treatment
after the biopsy was obtained.
3.2. Histopathologicalevaluation
All human biopsies were constituted by adequate fragments
according to Banﬀ criteria [15] showing no acute rejection
(n = 5), grade IA acute rejection (n = 5), or grade IIA
acute rejection (n = 5) (see Figure 1). In the no acute re-
jection group the peritubular capillary endothelial cells have
a normal shape and an elongated cytoplasm. In the acute re-
jection grade IA the lumen size is unchanged but populated
with numerous inﬂammatory cells adhering to swollen en-
dothelial cells. In the acute rejection IIA, the lumen is di-
lated, some swollen endothelial cells seemed to be detached
from the basement membrane and inﬂammatory cells have
migrated from the lumen to the interstitium.
3.3. Immunohistochemistry
There was no diﬀerence in CD34 staining between the 3
groups. VE-Cadherin staining was diﬀerentially expressed
between the 3 groups (P = .02). In no acute rejection group
VE-Cadherin stained cells represented 1.65 ± 0.71% of the
surface examined compared to 1.62 ± 0.34% in acute rejec-
tion grade IA and 0.75 ± 0.31% in acute rejection grade IIA
(see Figure 2). VE-Cadherin expression was signiﬁcantly re-
d u c e di na c u t er e j e c t i o ng r a d eI I Aw h e nc o m p a r e dt on o
acute rejection (P = .01) and to acute rejection grade IA
(P = .02). There was no diﬀerence in VE-Cadherin expres-
sion between acute rejection grade IA and no acute rejec-
tion group (P = .7). Figure 3 shows VE-Cadherin staining
as a strong, thin, linear staining on peritubular endothelial
cells in renal biopsies showing no rejection or acute rejection
grade IA compared to acute rejection grade IIA. CD34 stain-
ing conﬁrmed the staining of VE-Cadherin on peritubular
endothelial cells (see Figure 3).
4. DISCUSSION
The working hypothesis in this study is that the endothelium
lining the vessel wall of the donor kidney is ﬁrst to be in con-
tact with host cells and is subjected to immunological inter-
actions. Such interactions result in the over and under ex-
pression of some molecules. These molecules can facilitate
the adhesion and transmigration of lymphocytes in the re-
nal tissue leading to damage and ultimately to graft failure.
We have previously demonstrated by macroarrays, immuno-
histochemistry, and Q-PCR that VE-Cadherin is under ex-
pressedinacuterejectionfollowingmurineandhumanheart
transplantation [14]. In the current investigation, we bring
evidence for the ﬁrst time that VE-Cadherin is implicated
also in acute rejection following renal transplantation.
Lymphocyte adhesion to the vascular lining accompanies
the ﬁrst stages of the acute rejection reaction. The ability
of endothelial cells to adhere lymphocytes is not a constant
or a static phenomenon. Several cytokines and adhesion
molecules have shown to increase lymphocyte binding to
and penetration through endothelial cells [16]. In response4 Journal of Biomedicine and Biotechnology
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Figure 2: Immunohistochemical staining grade of VE-Cadherin on
endothelial cells. ∗P<. 05 acute rejection grade IIA versus acute
rejection grade IA; †P<. 05 acute rejection grade IIA versus no
acute rejection.
to cytokines and to the expression of endothelial cells adhe-
sion molecules, leukocytes ﬁrst roll on the endothelial sur-
face. Binding to endothelium is necessary, but not a suﬃ-
cient request for the leukocyte to get into tissue. This stage
is followed by a ﬁrm adhesion, and then by a rapid transmi-
gration of leukocytes through endothelial intercellular junc-
tions. Renkonen et al. [13] suggested and conﬁrmed the hy-
pothesis that the peritubular capillary endothelium is the site
of entry of lymphocytes into rejecting kidney allografts. The
authors showed that the increase in lymphocyte binding to
peritubular capillaries precede the peak of leukocyte accu-
mulationinthegraft.Lightandelectronmicroscopyrevealed
a marked activation of peritubular capillary endothelial cells
in allografts, whereas these alterations were less severe or ab-
sent in syngenic controls and normal kidneys.
VE-Cadherin is an endothelial-speciﬁc membrane pro-
tein, present in adherent junctions of endothelial cells and
responsiblefortheendothelialcell-celladhesion.Suzukietal.
[10] ﬁrst described it and it was initially denoted cadherin-
5. Lampugnani et al. [11] studied cultured endothelial cells
monolayers by immunoﬂuorescence microscopy. They de-
scribed VE-Cadherin as an endothelial-speciﬁc membrane
protein with a thin, sharp continuous line highlighting the
margins of each cell. It was present at the appositional sur-
faces of cultured cells only on reaching conﬂuency. They ob-
served that if the endothelial permeability was increased its
distribution was punctuated and could be found only at in-
tercellularcontactsinafewareas.Sincethen,variousauthors
demonstrated the properties of cell-cell adhesion of the VE-
Cadherin and the relationship of its diminution with the in-
crease of the endothelial permeability [17–20].
VE-Cadherin
(a)
CD 34
(b)
VE-Cadherin
(c)
CD 34
(d)
VE-Cadherin
(e)
CD 34
(f)
Figure 3: VE-Cadherin and CD34 immunohistochemical staining
offrozenrenalbiopsyserialsections(X400).(a),(b)Noacuterejec-
tion. (c), (d) Acute rejection grade IA. (e), (f) Acute rejection grade
IIA. (a), (c) and (e): VE-Cadherin staining on peritubular endothe-
lial cells (arrows). (b), (d) and (f): CD34 staining on peritubular
endothelial cells (arrows).
In our study, we found the same kind of staining de-
scribed as a thin, continuous line in the margins of renal per-
itubular human endothelial cells. Cell adhesion molecules,
mediating leukocyte adhesion to endothelial cells, have been
shown to aﬀect gene transcription in these cells. Previ-
ous studies [1, 11, 12] have demonstrated that through
their adhesion, leukocyte could transfer intracellular sig-
nals to endothelial cells in diﬀerent ways. Del Maschio
et al. [21] suggested that these intracellular signals could
induce endothelial intercellular disorganisation. They found
that leukocyte adhesion to endothelial cells was related toAna Roussouli` eres et al. 5
a reduced VE-Cadherin expression that could increase en-
dothelial permeability. An alternative explanation for adher-
ent junction’s disorganisation is the release of lytic enzymes
from the PMN that can be responsible for VE-Cadherin di-
gestion and junction disassembly. VE-Cadherin is particu-
larly susceptible to proteolytic digestion [11]. Such poten-
tial release of proteolytic enzymes [22], by activated leuko-
cytes,mayleadtocleavageoftheextracellulardomainofVE-
Cadherin, and an increase in the permeability in areas bear-
ing deposited leukocytes. Moreover, other authors [23, 24]
have reported changes in cytosolic Ca2+ level in endothelial
cells during the adhesion of polymorphonuclear leukocyte.
The polymorphonuclear leukocyte adherence could induce a
series of endothelial intracellular responses leading a detach-
ment of catenins from VE-Cadherin. It is conceivable that
in acute rejection after solid organ transplantation activated
lymphocytes adhering to vascular endothelial cells could af-
fect the latter cells by inducing the disappearance of VE-
Cadherin from endothelial adherent junctions. Such action
could result in a signiﬁcant increase in endothelial perme-
ability due to the disassembly of endothelial adherent junc-
tions.
VE-Cadherin was also investigated in other settings than
acute rejection after solid organ transplantation. Sutton et
al. [25] studied the immunohistochemical expression of VE-
Cadherin in an animal model of renal ischemia. Renal is-
chemia was induced by clamping the renal pedicule for
32 minutes. The authors observed that 24 hours after is-
chemia, the majority of the renal microvasculature did not
stain for VE-Cadherin. They observed also that 72 hours af-
ter ischemia, VE-Cadherin staining in the renal microvas-
culature was similar to that observed under physiological
conditions. Cerini et al. [26] studied the in vitro eﬀect of
the uremic retention solute p-cresol observed in chronic re-
nal failure. They observed an increase in endothelial per-
meability associated with a decreased staining of junctional
VE-Cadherin.
In summary, in this study we have demonstrated for
the ﬁrst time a correlation between the expression of VE-
Cadherin present in peritubular endothelial cells and acute
allograft rejection after human renal transplantation. The
under expression of VE-Cadherin in peritubular capillaries
in acute rejection after kidney transplantation could be re-
sponsible for the lymphocyte transmigration into intersti-
tial tissues leading to graft dysfunction. Preventing the down
regulation of VE-Cadherin could conceivably prevent severe
acute graft rejection.
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